
Olmefast AH 40mg/5mg/12.5mg Tablet
Marketer
Cadbless Life Care
Salt Composition
Olmesartan Medoxomil (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Olmefast AH 40mg/5mg/12.5mg Tablet
Tenopress 40mg/5mg/12.5mg tablets combine medications to manage hypertension when monotherapy proves insufficient. This treatment lowers elevated blood pressure, mitigating the risk of future strokes and heart attacks. Tenopress may be taken with or without food; dosage is individualized and should be consumed consistently daily. Continue this regimen as directed by your physician; discontinuation may increase stroke or heart attack risk. Containing a diuretic, increased urination is expected; avoid late-evening doses. Regular use maximizes efficacy, even in the absence of noticeable symptoms. Common side effects include fatigue, altered taste, dizziness, headache, and ankle edema. Report any persistent, worsening, or bothersome side effects to your physician immediately. Increase fluid intake to counter potential dehydration symptoms. Prior to commencing treatment, inform your physician of any kidney or liver conditions, pregnancy, breastfeeding, or concurrent medications, particularly those for cardiac or hypertensive management. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is essential to ensure therapeutic efficacy.
Uses of Olmefast AH 40mg/5mg/12.5mg Tablet
Elevated arterial blood pressure
Major Benefits of Olmefast AH 40mg/5mg/12.5mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Olmefast AH 40mg/5mg/12.5mg Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Olmefast AH 40mg/5mg/12.5mg Tablet:
- Headache
- Dizziness
- Nausea
- Upper respiratory tract infection
- Fatigue
- Urinary tract infection
- Diarrhea
- Joint swelling
- Peripheral edema
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Muscle spasm
- Hypotension (low blood pressure)
- Increased creatinine level in blood
- Increased blood urea
- Increased uric acid level in blood
How to use Olmefast AH 40mg/5mg/12.5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Olmefast AH 40mg/5mg/12.5mg tablets can be administered with or without food, although consistent daily timing is recommended.
How Olmefast AH 40mg/5mg/12.5mg Tablet works:
Olmefast AH 40mg/5mg/12.5mg tablets contain olmesartan medoxomil, amlodipine, and hydrochlorothiazide, three medications working synergistically to reduce blood pressure. Olmesartan medoxomil, an angiotensin II receptor antagonist (ARB), and amlodipine, a calcium channel blocker (CCB), both promote vasodilation, leading to decreased blood pressure. Hydrochlorothiazide, a diuretic, facilitates the excretion of excess fluid and electrolytes, contributing to lower blood pressure through diuresis and improved vascular tone.
SAFETY ADVICE
AlcoholUNSAFE
Combining Olmefast AH 40mg/5mg/12.5mg tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Olmefast AH 40mg/5mg/12.5mg tablets is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
Using Olmefast AH 40mg/5mg/12.5mg tablets while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Olmefast AH 40mg/5mg/12.5mg Tablet side effects. These side effects can include dizziness, headache, nausea, or fatigue, potentially impacting concentration and driving safety.
KidneyCAUTION
Individuals with severe kidney impairment should exercise caution when using Olmefast AH 40mg/5mg/12.5mg tablets. Dosage modification may be necessary; physician consultation is advised. Olmefast AH 40mg/5mg/12.5mg tablets are not recommended for patients with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Olmefast AH 40mg/5mg/12.5mg tablets cautiously. Dosage modification of Olmefast AH 40mg/5mg/12.5mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Olmefast AH 40mg/5mg/12.5mg Tablet :
Should you forget a dose of Olmefast AH 40mg/5mg/12.5mg Tablet, take it immediately if possible. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Olmefast AH 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Heart |
